ANDA 78228, held by Rising. Hydromorphone Hydrochloride.
As of Nov 16, 2026, ANDA 78228 (Hydromorphone Hydrochloride), held by Rising, was first approved by FDA on Apr 14, 2010, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 14, 2010 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydromorphone Hydrochloride10MG/ML · injectable;injection | Hydromorphone Hydrochloride | Rx |
| Apr 24, 2025 | Supplement 10Labeling · Standard review | Approved | None posted |
| May 20, 2020 | Supplement 7Labeling · Standard review | Approved | None posted |
| May 20, 2020 | Supplement 3Labeling · Standard review | Approved | None posted |
| Feb 4, 2015 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 14, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters